Skip to main content
Trials logoLink to Trials
. 2023 Nov 21;24:744. doi: 10.1186/s13063-023-07763-6

Correction: Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharing

Martin Law 1,2,, Dominique-Laurent Couturier 1,3, Babak Choodari-Oskooei 4, Phillip Crout 1, Carrol Gamble 5, Peter Jacko 6,7, Philip Pallmann 8, Mark Pilling 9, David S Robertson 1, Michael Robling 8, Matthew R Sydes 4,10, Sofía S Villar 1, James Wason 11, Graham Wheeler 12, S Faye Williamson 11, Christina Yap 13, Thomas Jaki 1,14
PMCID: PMC10664262  PMID: 37990330

Correction: BMC Trials 24, 640 (2023)

https://doi.org/10.1186/s13063-023-07576-7

Following publication of the original article [1], we have been informed that affiliation for Graham Wheeler was incorrectly presented. The correct affiliation at the time of manuscript submission is Imperial Clinical Trials Unit, Imperial College London.

Originally published affiliation: “Present address: Statistics & Data Science Innovation Hub, GSK, Brentford, UK”.

The original article has been corrected.

Reference

  • 1.Law M, et al. Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharing. BMC Trials. 2023;24:640. doi: 10.1186/s13063-023-07576-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Trials are provided here courtesy of BMC

RESOURCES